PortfoliosLab logoPortfoliosLab logo
SANA vs. RIVN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SANA vs. RIVN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sana Biotechnology, Inc. (SANA) and Rivian Automotive, Inc. (RIVN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SANA vs. RIVN - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SANA
Sana Biotechnology, Inc.
-25.06%149.69%-60.05%3.29%-74.48%-26.07%
RIVN
Rivian Automotive, Inc.
-24.20%48.20%-43.31%27.29%-82.23%2.94%

Fundamentals

Market Cap

SANA:

$772.36M

RIVN:

$18.42B

EPS

SANA:

-$0.97

RIVN:

-$3.03

PB Ratio

SANA:

4.80

RIVN:

4.01

Total Revenue (TTM)

SANA:

$0.00

RIVN:

$5.39B

Gross Profit (TTM)

SANA:

$0.00

RIVN:

$71.00M

EBITDA (TTM)

SANA:

-$250.32M

RIVN:

-$2.69B

Returns By Period

The year-to-date returns for both investments are quite close, with SANA having a -25.06% return and RIVN slightly higher at -24.20%.


SANA

1D
5.90%
1M
-26.51%
YTD
-25.06%
6M
-17.57%
1Y
103.33%
3Y*
-2.29%
5Y*
-37.51%
10Y*

RIVN

1D
-0.73%
1M
-0.47%
YTD
-24.20%
6M
2.26%
1Y
12.50%
3Y*
-1.18%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SANA vs. RIVN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SANA
SANA Risk / Return Rank: 7272
Overall Rank
SANA Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
SANA Sortino Ratio Rank: 7777
Sortino Ratio Rank
SANA Omega Ratio Rank: 7272
Omega Ratio Rank
SANA Calmar Ratio Rank: 7070
Calmar Ratio Rank
SANA Martin Ratio Rank: 6767
Martin Ratio Rank

RIVN
RIVN Risk / Return Rank: 5050
Overall Rank
RIVN Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
RIVN Sortino Ratio Rank: 5151
Sortino Ratio Rank
RIVN Omega Ratio Rank: 4747
Omega Ratio Rank
RIVN Calmar Ratio Rank: 5353
Calmar Ratio Rank
RIVN Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SANA vs. RIVN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sana Biotechnology, Inc. (SANA) and Rivian Automotive, Inc. (RIVN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SANARIVNDifference

Sharpe ratio

Return per unit of total volatility

0.98

0.20

+0.79

Sortino ratio

Return per unit of downside risk

1.97

0.88

+1.09

Omega ratio

Gain probability vs. loss probability

1.24

1.10

+0.14

Calmar ratio

Return relative to maximum drawdown

1.49

0.51

+0.98

Martin ratio

Return relative to average drawdown

3.07

0.96

+2.11

SANA vs. RIVN - Sharpe Ratio Comparison

The current SANA Sharpe Ratio is 0.98, which is higher than the RIVN Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of SANA and RIVN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SANARIVNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.98

0.20

+0.79

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.32

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.32

-0.45

+0.13

Correlation

The correlation between SANA and RIVN is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SANA vs. RIVN - Dividend Comparison

Neither SANA nor RIVN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SANA vs. RIVN - Drawdown Comparison

The maximum SANA drawdown since its inception was -96.92%, roughly equal to the maximum RIVN drawdown of -95.12%. Use the drawdown chart below to compare losses from any high point for SANA and RIVN.


Loading graphics...

Drawdown Indicators


SANARIVNDifference

Max Drawdown

Largest peak-to-trough decline

-96.92%

-95.12%

-1.80%

Max Drawdown (1Y)

Largest decline over 1 year

-54.73%

-38.84%

-15.89%

Max Drawdown (5Y)

Largest decline over 5 years

-95.83%

Current Drawdown

Current decline from peak

-92.99%

-91.31%

-1.68%

Average Drawdown

Average peak-to-trough decline

-81.10%

-86.19%

+5.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.57%

20.90%

+5.67%

Volatility

SANA vs. RIVN - Volatility Comparison

Sana Biotechnology, Inc. (SANA) has a higher volatility of 24.65% compared to Rivian Automotive, Inc. (RIVN) at 17.47%. This indicates that SANA's price experiences larger fluctuations and is considered to be riskier than RIVN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SANARIVNDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.65%

17.47%

+7.18%

Volatility (6M)

Calculated over the trailing 6-month period

67.60%

52.27%

+15.33%

Volatility (1Y)

Calculated over the trailing 1-year period

106.47%

64.68%

+41.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

118.85%

78.23%

+40.62%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

118.78%

78.23%

+40.55%

Financials

SANA vs. RIVN - Financials Comparison

This section allows you to compare key financial metrics between Sana Biotechnology, Inc. and Rivian Automotive, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
1.29B
(SANA) Total Revenue
(RIVN) Total Revenue
Values in USD except per share items